Allergy Diagnostics Market to Showcase Promising Growth till 2024

Allergy Diagnostics Market by Product (Assay Kits, Immunoassay and Elisa Analyzers, Luminometers, Services), Allergens (Food, Inhaled, Drug), Tests (In Vivo, In Vitro), End Users (Hospital, Diagnostic Laboratory, Research) - Global Forecast to 2024

Meticulous Research® – Meticulous Research® in its latest publication on Allergic Diagnostics market titled “Allergy Diagnostics Market by Product (Assay Kits, Immunoassay & Elisa Analyzers, Luminometers, Services), Allergens (Food, Inhaled, Drug), Tests (In Vivo, In Vitro), End Users (Hospital, Diagnostic Laboratory, Research) - Global Forecast to 2024”

Allergy is a type of reaction of immune systems and can appear in many forms and cause many symptoms such as sneezing, respiratory symptoms such as asthma or hay fever, itching, skin rashes, or generalized reaction such as anaphylaxis. The burden of allergic diseases is growing across the globe. According to European Academy of Allergy and Clinical Immunology 2016, allergy is the most common chronic disease in Europe. Around 20% of patients with allergies struggle daily with the fear of a possible asthma attack, anaphylactic shock, or even death from an allergic reaction. According to American College of Allergy, Asthma, and Immunology (ACAAI), allergies are the 6th leading cause of chronic illness in the U.S and annual cost of allergies exceeds $18 billion.

Increasing incidence and economic burden of allergic diseases, growing environmental pollution, and improving reimbursement scenario for allergy diagnosis in developed countries are key factors driving the growth of this market. Limited awareness about allergy diseases especially in developing countries and high capital investment for small laboratories may hinder the growth of this market.

Based on product & service, the global allergy diagnostics market is segmented into assay kits, instruments, and services. Assay kits accounted for the largest share of this market in 2018. The large share of this segment is mainly attributed to widespread availability, lower cost and significant consumption of assay kits in allergy testing.

Based on end user, the global allergy diagnostics market is segmented into diagnostic laboratories, hospital-based laboratories, academic and research institutes, and other end users. Diagnostic laboratories are expected to dominate the global allergy diagnostics market, by end user in 2018. The large share and high growth of this segment is mainly attributed to increasing number of diagnostic centers, rising investment and improving infrastructure of diagnostic labs, and greater preference and convenience to conduct these tests at these centers.

Browse in-depth Report on:

Future Outlook

Percutaneous skin prick tests (SPT) have been considered the preferred method for allergy diagnostics. However, although molecular-based allergy diagnostics (MA-Dx) is currently reserved for situations of complex allergies and polysensitization, it is likely that in the future, MA-Dx will play a bigger role in the evaluation of allergic patients.

Biomérieux SA (France), Hitachi Chemical Co., Ltd. (Japan), Hob Biotech Group Suzhou Co., Ltd. (China), Hycor Biomedical, Inc. (U.S.), Lincoln Diagnostics, Inc. (U.S.), Omega Diagnostics Group PLC (U.K.), R-Biopharm AG (Germany), Stallergenes Greer (U.K.), Siemens AG (Germany), Thermo Fisher Scientific Inc. (U.S.) are some of the key players operating in this market. These players are adopting various organic and inorganic growth strategies in order to strengthen their presence and customer base.

Key Topics Covered in This Report:
1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Market Estimation

3 Executive Summary

4 Market Insights
4.1 Introduction
4.2 Drivers
4.2.1 Rising Environmental Pollution Levels
4.2.2 High Incidence and Large Economic Burden of Allergic Diseases
4.2.3 Technological Advancements
4.2.4 Improving Coverage for Allergy Diagnosis
4.3 Restraints
4.3.1 Lack of awareness of Allergic Diseases
4.3.2 Issues Related to the Affordability of Allergy Diagnostics Instruments Among Small
Laboratories and Physician Clinics
4.4 Opportunities
4.4.1 Emerging Markets

5 Global Allergy Diagnostics Market, by Product & Service
5.1 Introduction
5.2 Assay Kits
5.3 Instruments
5.3.1 Immunoassay Analyzers
5.3.2 Luminometers
5.3.3 ELISA Analyzers
5.3.4 Other Instruments
5.4 Services

6 Global Allergy Diagnostics Market, By Test
6.1 Introduction
6.2 In Vitro Tests
6.3 In Vivo Tests

7 Global Allergy Diagnostics Market, By Allergen
7.1 Introduction
7.2 Inhaled Allergens
7.3 Food Allergens
7.4 Drug Allergens
7.5 Other Allergens

10 Global Allergy Diagnostics Market, By End User
10.1 Introduction
10.2 Diagnostic Laboratories
10.3 Hospital-Based Laboratories
10.4 Academic Research Institutes
10.5 Other End Users

11 Global Allergy Diagnostics Market, By Region
11.1 Introduction
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 U.K.
11.3.3 France
11.3.4 Italy
11.3.5 Spain
11.3.6 RoE
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 RoAPAC
11.5 Rest of the World
11.5.1 Latin America
11.5.2 Middle East & Africa

12 Competitive Landscape
12.1 Introduction
12.2 Company Benchmarking
12.3 Market Share Analysis

13 Company Profiles
13.1 Biomérieux SA
13.1.1 Business Overview
13.1.2 Financial Portfolio
13.1.3 Product Portfolio
13.1.4 Strategic Developments
13.2 Hitachi Chemical Co., Ltd.
13.2.1 Business Overview
13.2.2 Financial Portfolio
13.2.3 Product Portfolio
13.2.4 Strategic Developments
13.3 Hob Biotech Group Suzhou Co., Ltd.
13.3.1 Business Overview
13.3.2 Financial Portfolio
13.3.3 Product Portfolio
13.3.4 Strategic Developments
13.4 Hycor Biomedical, Inc.
13.4.1 Business Overview
13.4.2 Financial Portfolio
13.4.3 Product Portfolio
13.4.4 Strategic Developments
13.5 Lincoln Diagnostics, Inc.
13.5.1 Business Overview
13.5.2 Financial Portfolio
13.5.3 Product Portfolio
13.5.4 Strategic Developments
13.6 Omega Diagnostics Group PLC
13.6.1 Business Overview
13.6.2 Financial Portfolio
13.6.3 Product Portfolio
13.6.4 Strategic Developments
13.7 R-Biopharm AG
13.7.1 Business Overview
13.7.2 Financial Portfolio
13.7.3 Product Portfolio
13.7.4 Strategic Developments
13.8 Stallergenes Greer
13.8.1 Business Overview
13.8.2 Financial Portfolio
13.8.3 Product Portfolio
13.8.4 Strategic Developments
13.9 Siemens AG
13.9.1 Business Overview
13.9.2 Financial Portfolio
13.9.3 Product Portfolio
13.9.4 Strategic Developments
13.10 Thermo Fisher Scientific Inc.
13.10.1 Business Overview
13.10.2 Financial Portfolio
13.10.3 Product Portfolio
13.10.4 Strategic Developments

14 Appendix

Download free sample report and gain crucial industry insights @

Contact Info:
Name: Khushal
Email: Send Email
Organization: Meticulous Market Research Pvt. Ltd
Address: Pune,India
Phone: +91-744-7780008

Release ID: 88889977